Michael He

Postdoctoral Fellow, Princess Margaret Cancer Centre, University Health Network
  • Princess Margaret Cancer Centre, University Health Network
  • Canada

About Michael He

Michael is studying treatment resistance and defining molecular vulnerabilities in B-cell lymphoma using cutting-edge functional genomics and other multi-omics technologies. His ultimate goal is to identify and validate therapeutic strategies and biomarkers to rationalize the clinical use of novel agents in treating B-cell lymphoma.

Intro Content

Contributor Leukemia

Treatment resistance in diffuse large B-cell lymphoma: where, what and how

Where does it come from? What is the molecular basis? How can we manage it? These are the three key questions in terms of treatment resistance in diffuse large B-cell lymphoma. Herein, we comprehensively describe the sources, the molecular mechanisms and the ways to manage treatment resistance.

Topics

Channels contributed to:

Behind the paper

Online Elsewhere